Table 5.
Comparison of c-Myc expression among varied groups
| Items | RFH | FL | GCB DLBCL | non-GCB DLBCL | BL |
|---|---|---|---|---|---|
| RFH | - | 0.103 | < 0.001 | < 0.001 | < 0.001 |
| FL | - | - | < 0.001 | < 0.001 | < 0.001 |
| GCB DLBCL | - | - | - | 0.135 | 0.738 |
| non-GCB DLBCL | - | - | - | - | 0.082 |
| BL | - | - | - | - | - |
Data was presented as P value. c-Myc expression was scored as 0-Negative (-), 1-Positive (+), 2-Positive (++), 3-Positive (+++). Comparison was determined by Wilcoxon rank sum test. P < 0.05 was considered as significant and presented as bold font. c-Myc, proto-oncogene c-Myc; RFH, reactive follicular hyperplasia; FL, follicular lymphoma; GCB DLBCL, germinal center B-cell-like diffuse large B-cell lymphoma; non-GCB DLBCL, non-germinal center B-cell-like diffuse large B-cell lymphoma; BL, Burkitt’s lymphoma.